Shopping Cart 0
Cart Subtotal
USD 0

CareDx Inc (CDNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. It develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. CareDx also develop and commercialize post-transplant surveillance solutions to improve recipient outcomes. It offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

CareDx Inc (CDNA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

CareDx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

CareDx Inc, Medical Devices Deals, 2012 to YTD 2018 10

CareDx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

CareDx Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

CareDx Secures USD15 Million in Venture Funding 12

Partnerships 13

CareDx Enters into Co-Development Agreement with Horizon Discovery 13

Licensing Agreements 14

CareDx Amends Licensing Agreement with Stanford University 14

Equity Offering 15

CareDx Plans to Raise up to USD200 in Public Offering of Securities 15

CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 16

Acquisition 17

CareDx Acquires Allenex for up to USD34.1 Million 17

Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 19

CareDx Completes Acquisition of ImmuMetrix 20

Midroc Europe Acquires 36.3% Stake in Allenex for up to USD14.5 Million 21

Allenex To Sell 2.1% Stake In AnaMar To Koncentra For USD 0.3 Million 22

Allenex Sells Stake In Pharmacolog i Uppsala For USD 0.04 Million 23

CareDx Inc-Key Competitors 24

CareDx Inc-Key Employees 25

CareDx Inc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Financial Announcements 27

Aug 09, 2018: Caredx reports second quarter results 27

May 10, 2018: CareDx Reports First Quarter Results 29

Mar 22, 2018: CareDx Announces Fourth Quarter And FY2017 Financial Results 30

Jan 08, 2018: CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results 32

Nov 09, 2017: CareDx Reports Third Quarter 2017 Financial Results 33

Aug 10, 2017: CareDx Reports Second Quarter 2017 Financial Results 34

Jun 09, 2017: CareDx Reports First Quarter 2017 Financial Results 35

May 22, 2017: CareDx Reports Preliminary First Quarter 2017 Financial Results 36

Apr 21, 2017: CareDx Reports Fourth Quarter and Full Year 2016 Financial Results 37

Mar 15, 2017: CareDx Reports Preliminary Fourth Quarter and FY 2016 Financial Results 38

Corporate Communications 40

Jun 28, 2018: Flatiron Health CMO/CSO Joins CareDx Board of Directors 40

Apr 21, 2017: CareDx Appoints Michael Bell as Chief Financial Officer 41

Other Significant Developments 42

Jun 19, 2018: CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

CareDx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

CareDx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

CareDx Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

CareDx Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

CareDx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

CareDx Inc, Deals By Therapy Area, 2012 to YTD 2018 9

CareDx Inc, Medical Devices Deals, 2012 to YTD 2018 10

CareDx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

CareDx Secures USD15 Million in Venture Funding 12

CareDx Enters into Co-Development Agreement with Horizon Discovery 13

CareDx Amends Licensing Agreement with Stanford University 14

CareDx Plans to Raise up to USD200 in Public Offering of Securities 15

CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 16

CareDx Acquires Allenex for up to USD34.1 Million 17

Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 19

CareDx Completes Acquisition of ImmuMetrix 20

Midroc Europe Acquires 36.3% Stake in Allenex for up to USD14.5 Million 21

Allenex To Sell 2.1% Stake In AnaMar To Koncentra For USD 0.3 Million 22

Allenex Sells Stake In Pharmacolog i Uppsala For USD 0.04 Million 23

CareDx Inc, Key Competitors 24

CareDx Inc, Key Employees 25

CareDx Inc, Subsidiaries 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

CareDx Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. It develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. CareDx also develop and commercialize post-transplant surveillance solutions to improve recipient outcomes. It offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

CareDx Inc (CDNA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

CareDx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

CareDx Inc, Medical Devices Deals, 2012 to YTD 2018 10

CareDx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

CareDx Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

CareDx Secures USD15 Million in Venture Funding 12

Partnerships 13

CareDx Enters into Co-Development Agreement with Horizon Discovery 13

Licensing Agreements 14

CareDx Amends Licensing Agreement with Stanford University 14

Equity Offering 15

CareDx Plans to Raise up to USD200 in Public Offering of Securities 15

CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 16

Acquisition 17

CareDx Acquires Allenex for up to USD34.1 Million 17

Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 19

CareDx Completes Acquisition of ImmuMetrix 20

Midroc Europe Acquires 36.3% Stake in Allenex for up to USD14.5 Million 21

Allenex To Sell 2.1% Stake In AnaMar To Koncentra For USD 0.3 Million 22

Allenex Sells Stake In Pharmacolog i Uppsala For USD 0.04 Million 23

CareDx Inc-Key Competitors 24

CareDx Inc-Key Employees 25

CareDx Inc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Financial Announcements 27

Aug 09, 2018: Caredx reports second quarter results 27

May 10, 2018: CareDx Reports First Quarter Results 29

Mar 22, 2018: CareDx Announces Fourth Quarter And FY2017 Financial Results 30

Jan 08, 2018: CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results 32

Nov 09, 2017: CareDx Reports Third Quarter 2017 Financial Results 33

Aug 10, 2017: CareDx Reports Second Quarter 2017 Financial Results 34

Jun 09, 2017: CareDx Reports First Quarter 2017 Financial Results 35

May 22, 2017: CareDx Reports Preliminary First Quarter 2017 Financial Results 36

Apr 21, 2017: CareDx Reports Fourth Quarter and Full Year 2016 Financial Results 37

Mar 15, 2017: CareDx Reports Preliminary Fourth Quarter and FY 2016 Financial Results 38

Corporate Communications 40

Jun 28, 2018: Flatiron Health CMO/CSO Joins CareDx Board of Directors 40

Apr 21, 2017: CareDx Appoints Michael Bell as Chief Financial Officer 41

Other Significant Developments 42

Jun 19, 2018: CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

CareDx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

CareDx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

CareDx Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

CareDx Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

CareDx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

CareDx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

CareDx Inc, Deals By Therapy Area, 2012 to YTD 2018 9

CareDx Inc, Medical Devices Deals, 2012 to YTD 2018 10

CareDx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

CareDx Secures USD15 Million in Venture Funding 12

CareDx Enters into Co-Development Agreement with Horizon Discovery 13

CareDx Amends Licensing Agreement with Stanford University 14

CareDx Plans to Raise up to USD200 in Public Offering of Securities 15

CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 16

CareDx Acquires Allenex for up to USD34.1 Million 17

Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 19

CareDx Completes Acquisition of ImmuMetrix 20

Midroc Europe Acquires 36.3% Stake in Allenex for up to USD14.5 Million 21

Allenex To Sell 2.1% Stake In AnaMar To Koncentra For USD 0.3 Million 22

Allenex Sells Stake In Pharmacolog i Uppsala For USD 0.04 Million 23

CareDx Inc, Key Competitors 24

CareDx Inc, Key Employees 25

CareDx Inc, Subsidiaries 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

CareDx Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.